Literature DB >> 8391656

Comparison of in vitro effects of cicletanine, its enantiomers and major metabolite on rat thoracic aorta.

E O Mikkelsen1, J Sehested, S H Poulsen.   

Abstract

The effects of cicletanine ((+/-)-cic)), its optical isomers (BN-50417,(+)-cic); (BN-50418,(-)-cic) and major metabolite (BN-50699,cic-Met) on active tension were investigated in rat thoracic aortas. (+/-)-cic, (+)-cic, (-)-cic shifted the K(+)-concentration response curve to the right and depressed the maximum contractile response. Cic-Met was devoid of inhibitory effect on K(+)-induced contractions. (-)-Pinacidil had a far more potent inhibitory effect on K(+)-induced contractions than the cicletanine enantiomers and shifted the K(+)-concentration response curve to the right without affecting the maximum contractile response. (+/-)-Cic and nifedipine caused a concentration-related inhibition of Ca(2+)-induced contractions. Nifedipine was far more potent than (+/-)-cic in this respect. The slope of the Schild plot for nifedipine was not different from unity contrary to the significantly different slope for (+/-)-cic. (+/-)-Cic, (+)-cic, (-)-cic and cic-Met (3 x 10(-5) M to 3 x 10(-4) M) caused a concentration-related relaxation of noradrenaline (NA), serotonin (5-HT) and prostaglandin F2 alpha (PGF2 alpha)-induced contractions. In NA-precontracted preparations (-)-cic (10(-4) M-3 x 10(-4) M) had a stronger relaxant effect than (+)-cic. Cic-Met was a weaker antagonist of NA-induced contractions than (+) and (-)-cic. The enantiomers were far less potent relaxing NA-induced contractions than phentolamine. (+)-Cic, (-)-cic and cic-Met had a similar relaxant effect on 5-HT-induced contractions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391656     DOI: 10.1007/bf00166749

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

Review 1.  Structure-activity relationships of K+ channel openers.

Authors:  G Edwards; A H Weston
Journal:  Trends Pharmacol Sci       Date:  1990-10       Impact factor: 14.819

2.  Antihypertensive effect of cicletanine is exaggerated in NaCl-sensitive hypertension.

Authors:  H K Jin; R H Yang; P Esunge; Y F Chen; J Durand; S Oparil
Journal:  Am J Med Sci       Date:  1991-06       Impact factor: 2.378

Review 3.  Calcium channels in smooth muscle.

Authors:  H Karaki; G B Weiss
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

4.  Effect of cicletanine on reperfusion-induced arrhythmias and ion shifts in isolated rat hearts.

Authors:  A Tosaki; M Koltai; D A Willoughby; P Braquet
Journal:  J Cardiovasc Pharmacol       Date:  1990-02       Impact factor: 3.105

5.  Activation of prostacyclin synthesis in cultured aortic smooth muscle cells by 'diuretic-antihypertensive' drugs.

Authors:  B Dorian; J Larrue; F V Defeudis; H Salari; P Borgeat; P Braquet
Journal:  Biochem Pharmacol       Date:  1984-07-15       Impact factor: 5.858

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  General pharmacology of cicletanine.

Authors:  F Clostre; A Etienne
Journal:  Drugs Exp Clin Res       Date:  1988

8.  Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.

Authors:  P J Silver; B O'Connor; W R Cumiskey; G Van Aller; L T Hamel; R G Bentley; E D Pagani
Journal:  J Pharmacol Exp Ther       Date:  1991-04       Impact factor: 4.030

9.  Effects of cicletanine on histamine-induced contractions of isolated rabbit mesenteric arteries.

Authors:  A B Ebeigbe; M Cabanie; T Godfraind
Journal:  Fundam Clin Pharmacol       Date:  1989       Impact factor: 2.748

10.  A patch-clamp study of the effects of cicletanine on whole-cell calcium current in ventricular myocytes.

Authors:  M P Gisbert; P F Mery; R Fischmeister
Journal:  Drugs Exp Clin Res       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.